Vriligy 60

The primary ingredient in Vriligy is Dapoxetine, a selective serotonin reuptake inhibitor (SSRI) designed specifically to address and prevent premature ejaculation in men.

 

Vriligy is utilized for treating premature ejaculation, a prevalent issue associated with sexual dysfunction in males. It is characterized as the occurrence of early ejaculation following minimal sexual stimulation before or shortly after penetration, often leading to distress and relationship challenges. The medication aims to enhance control over ejaculation and prolong the time before it happens during sexual intercourse for men experiencing persistent or recurrent PE.

 

Vriligy is a selective serotonin reuptake inhibitor (SSRI) tailored for premature ejaculation (PE), featuring a quick onset of action, achieving its maximum effect within 1-2 hours, and possessing a brief half-life, which allows for its rapid elimination from the body within 24 hours. The ejaculation process is a reflex regulated by the sympathetic nervous system. Once sexual stimulation reaches a certain level, sensory nerve cells in the spinal cord activate, sending nerve impulses to the brain, which then relays messages back to motor neurons controlling the penile muscles that contract to trigger ejaculation. This ejaculation reflex is believed to be influenced by serotonin, a crucial neurotransmitter involved in relaying nerve signals that facilitate communication between brain cells. It is thought that low serotonin levels in specific areas of the brain contribute to premature ejaculation.

 

Dapoxetine in Vriligy inhibits the reabsorption of serotonin from the synapse, which is the space between nerve cells where chemical signals are transmitted. By blocking the re-uptake of serotonin by the first nerve cell (pre-synaptic), more serotonin remains available for the receiving nerve cell (post-synaptic), allowing for prolonged communication between nerve cells. This effect of Dapoxetine in Vriligy aids in extending the capacity to engage in sexual activity without experiencing premature ejaculation, granting better control over ejaculation duration.

 

Common side effects reported by users of Vriligy tablets include headaches, gastrointestinal disturbances (such as nausea, diarrhea, dry mouth, and abdominal discomfort), dizziness, drowsiness, tremors, sleep difficulties, increased blood pressure, erectile dysfunction, and decreased libido.